Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP804318.RADBhXS-4-9BliMK-s_z_FMqZTnU_SEsh5eLjX5gKD0gE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP804318.RADBhXS-4-9BliMK-s_z_FMqZTnU_SEsh5eLjX5gKD0gE130_assertion type Assertion NP804318.RADBhXS-4-9BliMK-s_z_FMqZTnU_SEsh5eLjX5gKD0gE130_head.
- NP804318.RADBhXS-4-9BliMK-s_z_FMqZTnU_SEsh5eLjX5gKD0gE130_assertion wasGeneratedBy ECO_0000203 NP804318.RADBhXS-4-9BliMK-s_z_FMqZTnU_SEsh5eLjX5gKD0gE130_provenance.
- NP804318.RADBhXS-4-9BliMK-s_z_FMqZTnU_SEsh5eLjX5gKD0gE130_assertion wasDerivedFrom befree-20150227 NP804318.RADBhXS-4-9BliMK-s_z_FMqZTnU_SEsh5eLjX5gKD0gE130_provenance.
- NP804318.RADBhXS-4-9BliMK-s_z_FMqZTnU_SEsh5eLjX5gKD0gE130_assertion SIO_000772 23470485 NP804318.RADBhXS-4-9BliMK-s_z_FMqZTnU_SEsh5eLjX5gKD0gE130_provenance.
- NP804318.RADBhXS-4-9BliMK-s_z_FMqZTnU_SEsh5eLjX5gKD0gE130_assertion evidence source_evidence_literature NP804318.RADBhXS-4-9BliMK-s_z_FMqZTnU_SEsh5eLjX5gKD0gE130_provenance.
- NP804318.RADBhXS-4-9BliMK-s_z_FMqZTnU_SEsh5eLjX5gKD0gE130_assertion description "[The selectivity of TRAIL towards cancer cells has promoted clinical evaluation of recombinant human TRAIL (rhTRAIL) and its agonistic antibodies in treating several major human cancers including colon and non-Hodgkin's lymphoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP804318.RADBhXS-4-9BliMK-s_z_FMqZTnU_SEsh5eLjX5gKD0gE130_provenance.